Advertisement
U.S. markets open in 8 hours 7 minutes

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
233.97-1.81 (-0.77%)
At close: 04:00PM EDT
233.97 0.00 (0.00%)
After hours: 04:28PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close235.78
Open235.91
Bid245.29 x 800
Ask250.01 x 1400
Day's Range229.72 - 237.00
52 Week Range204.44 - 261.54
Volume431,435
Avg. Volume410,061
Market Cap11.01B
Beta (5Y Monthly)0.52
PE Ratio (TTM)11.80
EPS (TTM)19.82
Earnings DateMay 01, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est291.87
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-0% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for UTHR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • United Therapeutics Corporation
    Analyst Report: United Therapeutics CorporationUnited Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
    Rating
    Fair Value
    Economic Moat
    21 days agoMorningstar
View more
  • Insider Monkey

    30 Biggest Biotechnology Companies in the World

    In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]

  • Insider Monkey

    Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript

    Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript March 13, 2024 Liquidia Corporation misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.23. LQDA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome everyone to […]

  • Thomson Reuters StreetEvents

    Q4 2023 Liquidia Corp Earnings Call

    Q4 2023 Liquidia Corp Earnings Call